Swing Trader: Sector Rotation Strategy (TA&FA) Propels WAT to a 12.46% Gain
The recent performance of the stock WAT has highlighted the efficacy of the Swing Trader Sector Rotation Strategy, which utilizes a blend of technical and fundamental analysis (TA&FA). This strategy has generated a substantial return of 12.46% for the stock.
The strength of the strategy is underscored by the Relative Strength Index (RSI), a technical tool that gauges price momentum. The RSI Indicator for WAT bounced back from an oversold position on June 12, 2023. This signals a potential shift in the stock’s trajectory, moving from a bearish trend to a bullish one. Such a reversal often prompts traders to capitalize on this upward momentum by purchasing the stock or investing in call options.
Providing further support to this strategy, an analysis by the A.I.dvisor, which scrutinized 23 comparable instances when the RSI indicator rebounded from an oversold state, revealed a compelling trend. In 16 of the examined cases, the stock witnessed an increase in value. This statistic translates into a promising 70% probability of the stock moving higher.
This impressive performance of WAT demonstrates the potency of the Swing Trader Sector Rotation Strategy, as it adeptly employs technical and fundamental analysis to yield noteworthy results. As the RSI Indicator for WAT transitions out of the oversold domain, there is a persuasive case for expecting the stock's price to rise. It's an encouraging cue for traders to potentially reap significant benefits from this shift in momentum.
This assessment emphasizes the powerful potential of technical and fundamental analysis in charting a stock’s direction. By harnessing these insights, traders are well-equipped to make more informed and strategic investment decisions. Thus, the demonstrated success of WAT using the Swing Trader Sector Rotation Strategy further validates its effectiveness in today's complex market landscape.
The RSI Indicator for WAT moved out of oversold territory on April 09, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In of the 26 cases the stock moved higher. This puts the odds of a move higher at .
The Momentum Indicator moved above the 0 level on April 22, 2025. You may want to consider a long position or call options on WAT as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for WAT just turned positive on April 22, 2025. Looking at past instances where WAT's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WAT advanced for three days, in of 301 cases, the price rose further within the following month. The odds of a continued upward trend are .
WAT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 63 cases where WAT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The 50-day moving average for WAT moved below the 200-day moving average on April 28, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where WAT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for WAT entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. WAT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (17.730) is normal, around the industry mean (24.089). P/E Ratio (31.781) is within average values for comparable stocks, (79.080). Projected Growth (PEG Ratio) (3.342) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (6.906) is also within normal values, averaging (42.249).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of analytical technologies: liquid chromatography, mass spectrometry, and thermal analysis
Industry MedicalSpecialties